Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Sep;8(5):1018-20.
doi: 10.1128/CDLI.8.5.1018-1020.2001.

Determination of human immunodeficiency virus type 1 subtypes by a rapid method useful for the routine diagnostic laboratory

Affiliations

Determination of human immunodeficiency virus type 1 subtypes by a rapid method useful for the routine diagnostic laboratory

H H Kessler et al. Clin Diagn Lab Immunol. 2001 Sep.

Abstract

The existence of human immunodeficiency virus type 1 (HIV-1) subtypes has many important implications for the global evolution of HIV and for the evaluation of pathogenicity, transmissibility, and candidate HIV vaccines. The aim of this study was to establish a rapid method for determination of HIV-1 subtypes useful for a routine diagnostic laboratory and to investigate the distribution of HIV-1 subtypes in Austrian patients. Samples were tested by a subtyping method based on a 1.3-kb sequence of the polymerase gene generated by a commercially available drug resistance assay. The generated sequence was subtyped by means of an HIV sequence database. Results of 74 routine samples revealed subtype B (71.6%) as the predominant subtype, followed by subtype A (13.5%) and subtype C (6.8%). Subtypes E, F, G, and AE (CM240) were also detected. This subtyping method was found to be very easy to handle, rapid, and inexpensive and has proved suitable for high-throughput routine diagnostic laboratories. The specific polymerase gene sequence, however, must be existent.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Prevalence of HIV-1 subtypes in Austrian HIV-1 patients.

Similar articles

Cited by

References

    1. Adwan G, Papa A, Kouidou S, Alexiou S, Ialissiovas N, Itoutsos I, Kiosses V, Antoniadis A. Genetic heterogeneity of HIV-1 in Greece. Microbes Infect. 2000;2:353–357. - PubMed
    1. Alaeus A, Leitner T, Lidman K, Albert J. Most HIV-1 genetic subtypes have entered Sweden. AIDS. 1997;11:199–202. - PubMed
    1. Barlow K L, Tosswill J H, Clewley J P. Analysis and genotyping of PCR products of the Amplicor HIV-1 kit. J Virol Methods. 1995;52:65–74. - PubMed
    1. Carr J K, Salminen M O, Albert J, Sanders-Buell E, Gotte D, Birx D L, McCutchan F E. Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants. Virology. 1998;247:22–31. - PubMed
    1. Clevenbergh P, Durant J, Halfon P, del Giudice P, Mondain V, Montagne N, Schapiro J M, Boucher C A, Dellamonica P. Persisting long-term benefit of genotype-guided treatment for HIV-infected patients failing HAART. The Viradapt Study: week 48 follow-up. Antivir Ther. 2000;5:65–70. - PubMed